Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab

.

Source: OncoImmunology - March 5, 2019 Category: Cancer & Oncology Authors: Geoffrey Popinat St éphanie Cousse Lucas Goldfarb St éphanie Becker Isabelle Gardin Mathieu Sala ün S ébastien Thureau Pierre Vera Florian Guisier Pierre Decazes Source Type: research